The Amyloidosis Fellowship is a one-year program within the Division of Cardiovascular Medicine and the Knight Cardiovascular Institute.

OHSU is one of the only institutions in the country offering dedicated, comprehensive training in systemic amyloidosis within a single integrated program. You will develop deep expertise in the pathophysiology of amyloid disease, mastery of advanced multimodality imaging and meaningful engagement in clinical or basic research.

You will leave the program prepared to contribute as a clinical leader and investigator in the rapidly evolving field of amyloidosis.

Fellowship objectives

The fellowship aims to educate and produce subspecialists who will: 

• Become proficient and competent in the care of patients with amyloid cardiomyopathy
• Develop a deep understanding of the pathophysiology and literature that inform our treatment
• Participate in clinical and/or basic research to help further the communal knowledge of cardiac amyloidosis

Fellowship curriculum

The fellowship provides a mix of clinical training, didactics and dedicated time for research and scholarly activity. The program is designed to give you hands-on experience while also supporting research and learning in the field.

As part of the fellowship, you will work closely with faculty and teams across:

• Cardiology
• Oncology
• Neurology
• Nephrology

Clinical experiences include:

• Amyloidosis specialty clinic
• Subspecialty clinics
• Dedicated imaging days (echocardiogram, cardiac MRI, nuclear imaging)
• Cardiac catheterization laboratory
• Bone marrow biopsy
• Bone marrow transplant service
• Pathology rotations

You will develop expertise in multimodality imaging central to the diagnosis and management of cardiac amyloidosis, including:

• Strain echocardiography
• Three-dimensional echocardiography
• Contrast echocardiography
• Myocardial perfusion imaging
• Technetium pyrophosphate (PYP) imaging
• Cardiac MRI
• PET-MRI

This integrated imaging approach allows you to develop advanced diagnostic acumen in infiltrative cardiomyopathies.

Research

As part of the fellowship, you will develop a scientific question and, under the guidance of teaching staff and mentors, design a study aimed at answering that question. You will give a formal departmental presentation of your work, and it is expected that this will result in a presentation at a national meeting and/or publication within a peer-reviewed journal.

Educational components of the fellowship include:

• Morning and afternoon didactic sessions
• Structured research time
• Exposure to ongoing amyloidosis clinical trials
• Multidisciplinary case discussions
• Pathophysiology-focused teaching sessions

How to apply

To request an application packet, email our education manager, Ana Martin, at plesiaa@ohsu.edu.

In your application, include:

• Curriculum vitae
• USMLE or COMLEX scores
• Medical Student Performance Evaluation (MSPE)
• Three letters of recommendation (including one from the current or most recent program director)
• ECFMG certificate (for applicants trained outside the United States)

Eligibility requirements

Applicants must have completed an ACGME-accredited internal medicine residency. We strongly prefer that you have completed a cardiovascular disease fellowship.

Visa sponsorship is not available for this program, except for H1-B visa transfers.

Important dates

The fellowship’s annual start date is July 1. Applications are reviewed on a rolling basis upon receipt.

Current fellows

Meet our current Amyloidosis fellows.